High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population

References

• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China. Circulation. 2017;135(8):759–771. doi:10.1161/CIRCULATIONAHA.116.02525028052979
   PubMed Web of Science ®Google Scholar
• Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301–1310. doi:10.1056/NEJMoa06427817898099
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104(10):1108–1113. doi:10.1161/hc3501.09521411535564
   PubMed Web of Science ®Google Scholar
• Woodward M, Barzi F, Feigin V, et al. Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. Eur Heart J. 2007;28(21):2653–2660. doi:10.1093/eurheartj/ehm42717933756
   PubMed Web of Science ®Google Scholar
• Willey J, Gonzalez-Castellon M. Cholesterol level and stroke: a complex relationship. JAMA Intern Med. 2013;173(19):1765–1766. doi:10.1001/jamainternmed.2013.1010024000073
   PubMed Web of Science ®Google Scholar
• Huxley RR, Barzi F, Lam TH, et al. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation. 2011;124(19):2056–2064. doi:10.1161/CIRCULATIONAHA.111.02837321986289
   PubMed Web of Science ®Google Scholar
• Yang W, Xiao J, Yang Z, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125(18):2212–2221. doi:10.1161/CIRCULATIONAHA.111.06590422492668
   PubMed Web of Science ®Google Scholar
• SPARCL Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–559. doi:10.1056/NEJMoa06189416899775
   PubMed Web of Science ®Google Scholar
• Pedersen TR, Kjekshus J, Berg Ket al., Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet (London). 1995;345(8960):1274–1275. doi:10.1016/S0140-6736(95)90926-5
   Web of Science ®Google Scholar
• Sun L, Clarke R, Bennett D, et al. Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults. Nat Med. 2019;25(4):569–574. doi:10.1038/s41591-019-0366-x30858617
   PubMed Web of Science ®Google Scholar
• Choukem SP, Manases T, Nda-Mefoo JP, et al. Validation of the Friedewald formula for the estimation of low density lipoprotein cholesterol in a sub-Saharan African population. Clin Biochem. 2018;53:25–30. doi:10.1016/j.clinbiochem.2017.12.00829273329
   PubMed Web of Science ®Google Scholar
• Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22(3):312–318. doi:10.1161/01.STR.22.3.3122003301
   PubMed Web of Science ®Google Scholar
• Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34(3):623–631. doi:10.1161/01.STR.0000057812.51734.FF12624282
   PubMed Web of Science ®Google Scholar
• Willey JZ, Xu Q, Boden-Albala B, et al. Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol. 2009;66(11):1400–1406. doi:10.1001/archneurol.2009.21019901173
   PubMedGoogle Scholar
• Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007;68(8):556–562. doi:10.1212/01.wnl.0000254472.41810.0d17310025
   PubMed Web of Science ®Google Scholar
• Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255–2267.22085343
   PubMed Web of Science ®Google Scholar
• Landray MJ, Haynes R, Hopewell JC; Group HTC. et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014;371(3):203–212.25014686
   PubMed Web of Science ®Google Scholar
• Saito I, Yamagishi K, Kokubo Y, et al. Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: the Japan Public Health Center-based prospective (JPHC) study. Atherosclerosis. 2017;265:147–154. doi:10.1016/j.atherosclerosis.2017.08.03228888808
   PubMed Web of Science ®Google Scholar
• Soyama Y, Miura K, Morikawa Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke. 2003;34(4):863–868. doi:10.1161/01.STR.0000060869.34009.3812637692
   PubMed Web of Science ®Google Scholar
• Tall AR. An overview of reverse cholesterol transport. Eur Heart J. 1998;19 Suppl A:A31–5.9519340
   PubMed Web of Science ®Google Scholar
• Yoshikawa M, Sakuma N, Hibino T, Sato T, Fujinami T. HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2. Clin Biochem. 1997;30(3):221–225. doi:10.1016/S0009-9120(97)00031-39167898
   PubMed Web of Science ®Google Scholar
• Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol. 2003;23(10):1881–1888. doi:10.1161/01.ATV.0000091338.93223.E812920049
   PubMed Web of Science ®Google Scholar
• Ashby DT, Rye KA, Clay MA, Vadas MA, Gamble JR, Barter PJ. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler Thromb Vasc Biol. 1998;18(9):1450–1455. doi:10.1161/01.ATV.18.9.14509743234
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547–563. doi:10.1161/CIRCRESAHA.115.30624926892957
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–635. doi:10.1016/S0140-6736(14)61177-625131982
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Sarwar N, Perry P, et al.; Emerging Risk Factors C. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000. doi:10.1001/jama.2009.1619.19903920
   PubMed Web of Science ®Google Scholar
• Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation. 2001;104(25):3046–3051. doi:10.1161/hc5001.10062411748098
   PubMed Web of Science ®Google Scholar
• Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85(1):37–45. doi:10.1161/01.CIR.85.1.371728471
   PubMed Web of Science ®Google Scholar
• Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213–219. doi:10.1097/00043798-199604000-000148836866
   PubMedGoogle Scholar
• Gotto AM. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins. Am J Cardiol. 1990;66(6):A20–A3. doi:10.1016/0002-9149(90)90565-I
   PubMed Web of Science ®Google Scholar
• Tedla YG, Yano Y, Carnethon M, Greenland P. Association between long-term blood pressure variability and 10-year progression in arterial stiffness. Hypertension. 2017;69(1):118–127. doi:10.1161/HYPERTENSIONAHA.116.0842727849565
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke. 2000;31(8):1882–1888. doi:10.1161/01.STR.31.8.188210926951
   PubMed Web of Science ®Google Scholar